THE TUMOR-INHIBITORY EFFECTS OF THE METHYLHYDRAZINE DERIVATIVE RO 4-6467/1 (NSC-77213).
D000818:Animals; D000970:Antineoplastic Agents; D002279:Carcinoma 256, Walker; D002286:Carcinoma, Ehrlich Tumor; D005260:Female; D006801:Humans; D006834:Hydrazines; D008763:Methylhydrazines; D051379:Mice; D009374:Neoplasms, Experimental; D010600:Pharmacology; D051381:Rats; D012106:Research; D012510:Sarcoma 180; D014594:Uterine Neoplasms
D000970:Antineoplastic Agents; D006834:Hydrazines; D008763:Methylhydrazines
ANTINEOPLASTIC AGENTS; CARCINOMA 256, WALKER; CARCINOMA, EHRLICH TUMOR; EXPERIMENTAL LAB STUDY; HYDRAZINES; MICE; NEOPLASMS, EXPERIMENTAL; PHARMACOLOGY; RATS; SARCOMA 180, CROCKER; UTERINE NEOPLASMS